In addition to S1P, altered ceramide metabolism has also been linked to multiple myeloma with a main focus on aSMase; however, as discussed below, the understanding of the relationship between expression and activity of aSMase in multiple myeloma is still incomplete. This evidence concerns the gene SMPD1 and plasma cell myeloma.